Benign epilepsy in children

Journal of the Formosan Medical Association

Volumn 110, Issue 3, 2011, Pages 134-144

  Chan, Sook Cheng ^a   Lee, Wang Tso ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Absence epilepsy; Benign epilepsy; Juvenile myoclonic epilepsy; Panayiotopoulos syndrome; Rolandic epilepsy

Indexed keywords

BENIGN CHILDHOOD EPILEPSY; CHILDHOOD ABSENCE SEIZURE; EPILEPSY; HUMAN; INFANTILE SPASM; JUVENILE MYOCLONIC EPILEPSY; KNOWLEDGE; LENNOX GASTAUT SYNDROME; PANAYIOTOPOULOS SYNDROME; REVIEW; ROLANDIC EPILEPSY; SEIZURE;

EID: 79955580035     PISSN: None     EISSN: 09296646     Source Type: Journal    
DOI: 10.1016/S0929-6646(11)60023-5     Document Type: Review

References (70)

1. Capovilla G, Berg AT, Cross JH, et al. Workshop report: conceptual dichotomies in classifying epilepsies: partial versus generalized and idiopathic versus symptomatic. Epilepsia 2009;50:1648-9.
2. Willmore LJ. Treatment of benign epilepsy syndromes throughout life. Epilepsia 2001;42:6-9.
3. Fukuyama Y. Borderland of epilepsy with special reference with special reference to febrile convulsions and so-called infantile convulsion. Seishin Igaku (Clin Psychiatry) 1963; 5:211-23. [In Japanese].
4. Saadeldin IY, Housawi Y, AI Nemri A, et al. Benign familial and non-familial infantile seizures (Fukuyama-Watanabe-Vigevano syndrome): a study of 14 cases from Saudi Arabia. Brain Dev 2010;32:378-84.
5. Espeche A. Benign infantile seizures: a prospective study. Epilepsy Res 2010;89:96-103.
6. Xiao B, Deng FY, Xiong G, et al. Clinical and genetic study on a new Chinese family with benign familial infantile seizures. Eur J Neurol 2005;12:344-9.
7. Striano P, Bordo L, Lispi ML, et al. A novel SCN2A mutation in family with benign familial infantile seizures. Epilepsia 2006;47:218-20.
8. Weber YG, Jacob M, Weber G, et al. A BFIS-like syndrome with late onset and febrile seizures: suggestive linkage to chromosome 16p11.2-16q12.1. Epilepsia 2008;49:1959-64.
9. Herlenius E, Heron SE, Grinton BE, et al. SCN2A mutations and benign familial neonatal-infantile seizures: the phenotypic spectrum. Epilepsia 2007;48:1138-42.
10. Panayiotoupoulos CP. The Epilepsies. Chipping Norton, Oxfordshire: Bladon Medical Publishing, 2005:296-303.
11. Valentin A, Hindocha N, Osei-Lah A, et al. Idiopathic generalized epilepsy with absences: syndrome classification. Epilepsia 2007;48:2187-90.
12. Rubboli G, Gardella E, Capovilla G. Idiopathic generalized epilepsy (IGE) syndromes in development: IGE with absences of early childhood, IGE with phantom absences, and perioral myoclonia with absences. Epilepsia 2009;50(Suppl 5):24-8.
13. Caplan R, Siddarth P, Stahl L, et al. Childhood absence epilepsy: behavioral, cognitive, and linguistic co morbidities. Epilepsia 2008;49:1838-46.
14. Caplan R, Siddarth P, Vona P. Language in pediatric epilepsy. Epilepsia 2009;50:2397-407.
15. Duncan JS. Brain imaging in idiopathic generalized epilepsies. Epilepsia 2005;46(Suppl 9):108-11.
16. Caplan R, Levitt J, Siddarth P. Frontal and temporal volumes in childhood absence epilepsy. Epilepsia 2009;50:2466-72.
17. Moeller F, Siebner HR, Wolff S, et al. Simultaneous EEG-fMRI in drug-naive children with newly diagnosed absence epilepsy. Epilepsia 2008;49:1510-9.
18. Penovich PE, Willmore LJ. Use of a new antiepileptic drug or an old one as first drug for treatment of absence epilepsy. Epilepsia 2009;50(Suppl 8):37-41.
19. Coppola G, Auricchio G, Federico R, et al. Lamotrigine versus valproic acid as first-line monotherapy in newly diagnosed typical absence seizures: an open-label, randomized, parallel-group study. Epilepsia 2004;45:1049-53.
20. Noachtar S, Andermann E, Meyvisch P, et al; N166 Levetiracetam Study Group. Levetiracetam for the treatment of idiopathic generalized epilepsy with myoclonic seizures. Neurology 2008;70:607-16.
21. Cross JH. Topiramate monotherapy for childhood absence seizures: an open label pilot study. Seizure 2002;11:406-10.
22. Savic I, Lekvall A, Greitz D, et al. MR spectroscopy shows reduced frontal lobe concentrations of N-acetyl aspartate in patients with juvenile myoclonic epilepsy. Epilepsia 2000;41:290-6.
23. Lin K, Carrete H Jr, Lin J, et al. Magnetic resonance spectroscopy reveals an epileptic network in juvenile myoclonic epilepsy. Epilepsia 2009;50:1191-200.
24. Piazzini A, Turner K, Vignoli A, et al. Frontal cognitive dysfunction in juvenile myoclonic epilepsy. Epilepsia 2007;49:657-62.
25. Betting LE, Mory SB, Li LM, et al. Voxel-based morphometry in patients with idiopathic generalized epilepsies. NeuroImage 2006;32:498-502.
26. Pascalicchio TF, de Araujo Filho GH, da silva Noffs MH, et al. Neuropsychological profile of patients with juvenile myoclonic epilepsy: a controlled study of 50 patients. Epilepsy Behav 2007;10:263-7.
27. Swartz BE, Simpkins F, Halgren E, et al. Visual working memory in primary generalized epilepsy: an 18FDG-PET study. Neurology 1996;47:1203-12.
28. Roebling R, Scheerer N, Uttner I, et al. Evaluation of cognition, structural, and functional MRI in juvenile myoclonic epilepsy. Epilepsia 2009;50:2456-65.
29. Panayiotopoulos CP, Michael M, Sanders S, et al. Benign childhood focal epilepsies: assessment of established and newly recognized syndromes. Brain 2008;131:2264-86.
30. rd. Benign epilepsy with centrotemporal spikes. Epilepsia 2009;50(Suppl 8):10-5.
31. Fejerman N. Atypical rolandic epilepsy. Epilepsia 2009; 50(Suppl 7):9-12.
32. Bourgeois BF. Drug treatment of benign focal epilepsies of childhood. Epilepsia 2000;41:1057-8.
33. Ambrosetto G, Tassinari CA. Antiepileptic drug treatment of benign childhood epilepsy with rolandic spikes: is it necessary? Epilepsia 1990;31:802-5.
34. Ambrosetto G, Giovanardi RP, Tassinari CA. Predictive factors of seizure frequency and duration of antiepileptic treatment in rolandic epilepsy: a retrospective study. Brain Dev 1987;9:300-4.
35. Bouma PA, Bovenkerk AC, Westendorp RG, et al. The course of benign partial epilepsy of childhood with centrotemporal spikes: a meta-analysis. Neurology 1997;48:430-7.
36. Kossoff EH, Los JG, Boatman DF. A pilot study transitioning children onto levetiracetam monotherapy to improve language dysfunction associated with benign rolandic epilepsy. Epilepsy Behav 2007;11:514-7.
37. Bali B, Kull LK, Strug LJ, et al. Autosomal dominant inheritance of centrotemporal sharp waves in rolandic epilepsy families. Epilepsia 2007;48:2266-72.
38. Kugler SL, Bali B, Lieberman P, et al. An autosomal dominant genetically heterogeneous variant of rolandic epilepsy and speech disorder. Epilepsia 2008;49:1086-90.
39. Vadlamudi L, Kjeldsen MJ, Corey LA, et al. Analyzing the etiology of benign rolandic epilepsy: a multicenter twin collaboration. Epilepsia 2006;47:550-5.
40. Neubauer BA, Fiedler B, Himmelein B, et al. Centrotemporal spikes with rolandic epilepsy: linkage to chromosome 15q14. Neurology 1998;51:1608-12.
41. Strug LJ, Clarke T, Chiang T, et al. Centrotemporal sharp wave EEG trait in rolandic epilepsy maps to Elongator Protein Complex 4 (ELP4). Eur J Hum Genet 2009;17:1171-81.
42. Roll P, Rudolf G, Pereira S, et al. SRPX2 mutations in disorders of language cortex and cognition. Hum Mol Genet 2006;15:1195-207.
43. Royer-Zemmour B, Ponsole-Lenfant M, Gara H, et al. Epileptic and developmental disorders of the speech cortex: ligand/receptor interaction of wild-type and mutant SRPX2 with the plasminogen activator receptor uPAR. Hum Mol Genet 2008;17:3617-30.
44. Rudolf G, Valenti MP, Hirsch E, et al. From rolandic epilepsy to continuous spike-and-waves during sleep and Landau-Kleffner syndromes: insights into possible genetic factors. Epilepsia 2009;50(Suppl 7):25-8.
45. Riva D, Vago C, Franceschetti S, et al. Intellectual and language findings and their relationship to EEG characteristics in benign childhood epilepsy with centrotemporal spikes. Epilepsy Behav 2007;10:278-85.
46. Kavros PM, Clarke T, Strug LJ, et al. Attention impairment in rolandic epilepsy: systematic review. Epilepsia 2008;49:1570-80.
47. Clarke T, Strug LJ, Murphy PL, et al. High risk of reading disability and speech sound disorder in rolandic epilepsy families: case-control study. Epilepsia 2007;48:2258-65.
48. Baglietto MG, Battaglia FM, Nobili L, et al. Neuropsychological disorders related to interictal epileptic discharges during sleep in benign epilepsy of childhood with centrotemporal or Rolandic spikes. Dev Med Child Neurol 2001;43:407-12.
49. Wolff M, Weiskopf N, Serra E, et al. Benign partial epilepsy in childhood: selective cognitive deficits are related to the location of focal spikes determined by combined EEG/MEG. Epilepsia 2005;46:1661-7.
50. Deonna TW, Roulet E, Fontan D, et al. Speech and oromotor deficits of epileptic origin in benign partial epilepsy of childhood with rolandic spikes (BPERS). Relationship to the acquired aphasia epilepsy syndrome. Neuropediatrics 1993;24:83-7.
51. Monjauze C, Tuller L, Hommet C, et al. Language in benign childhood epilepsy with centro-temporal spikes abbreviated form: rolandic epilepsy and language. Brain Lang 2005;92:300-8.
52. Lillywhite LM, Saling MM, Harvey AS, et al. Neuropsychological and functional MRI studies provide converging evidence of anterior language dysfunction in BECTS. Epilepsia 2009;50:2276-84.
53. Boatman DF, Trescher WH, Smith C, et al. Cortical auditory dysfunction in benign rolandic epilepsy. Epilepsia 2008;49:1018-26.
54. Engel J Jr. Report of the ILAE classification core group. Epilepsia 2006;47:1558-68.
55. Panayiotopoulos CP. The birth and evolution of the concept of Panayiotopoulos syndrome. Epilepsia 2007;48:1041-3.
56. Capovilla G, Striano P, Beccaria F. Changes in Panayiotopoulos syndrome over time. Epilepsia 2009;50(Suppl 5):45-8.
57. Koutroumanidis M. Panayiotopoulos syndrome: an important electroclinical example of benign childhood system epilepsy. Epilepsia 2007;48:1044-53.
58. Taylor I, Berkovic SF, Kivity S, et al. Benign occipital epilepsies of childhood: clinical features and genetics. Brain 2008; 131:2287-94.
59. Ferrie CD, Caraballo R, Covanis A, et al. Autonomic status epilepticus in Panayiotopoulos syndrome and other childhood and adult epilepsies: a consensus view. Epilepsia 2007;48:1165-72.
60. Caraballo R, Cerśosimo R, Fejerman N. Panayiotopoulos syndrome: a prospective study of 192 patients. Epilepsia 2007;48:1054-61.
61. Durá-Travé T, Yoldi-Petri ME, Gallinas-Victoriano F. Panayiotopoulos syndrome: epidemiological and clinical characteristics and outcome. Eur J Neurol 2008;15:336-41.
62. Du JC, Chien YH, Weng WC, et al. Clinical analysis of childhood occipital lobe epilepsy in 43 Taiwanese patients. Pediatr Neurol 2007;36:387-92.
63. Schuele SU, Bermeo AC, Locatelli E, et al. Ictal asystole: a benign condition? Epilepsia 2008;49:168-71.
64. Covanis A. Panayiotopoulos syndrome: a benign childhood autonomic epilepsy frequently imitating encephalitis, syncope, migraine, sleep disorder, or gastroenteritis. Pediatrics 2006;118:e1237-43.
65. Yoshinaga H, Koutroumanidis M, Kobayashi K, et al. EEG dipole characteristics in Panayiotopoulos syndrome. Epilepsia 2006;47:781-7.
66. Hirano Y, Oguni H, Funatsuka M, et al. Neurobehavioral abnormalities may correlate with increased seizure burden in children with Panayiotopoulos syndrome. Pediatr Neurol 2009;40:443-8.
67. Ferrie C, Caraballo R, Covanis A, et al. Panayiotopoulos syndrome: a consensus view. Dev Med Child Neurol 2006;48:236-40.
68. Gastaut H. A new type of epilepsy: benign partial epilepsy of childhood with occipital spike-waves. Clin Electroencephalogr 1982;13:13-22.
69. Carabello RH, Cersósimo RO, Fejerman N. Childhood occipital epilepsy of Gastaut: a study of 33 patients. Epilepsia 2008;49:288-97.
70. Verrotti A, Parisi P, Loiacono G, et al. Levetiracetam monotherapy for childhood occipital epilepsy of Gastaut. Acta Neurol Scand 2009;120:342-6.